Our data provide the first evidence that pancreatic spinophilin protein interactions are modulated by obesity and that loss of spinophilin specifically in pancreatic β cells impacts whole body glucose tolerance. The gene discussed is PPP1R9B; the disease is obesity due to melanocortin 4 receptor deficiency.